KCT0004975招募中未知
A 8 week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of MJBIO-002 on Vaginal Health
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 50(Year)（—）
- 性别
- All
入选标准
- •1) Women of childbearing age over 19 years of age and under 50 years of age
- •2) A person with a score of 4-6 on the Nugent core.
- •3) A person who agrees to participate in the human application test before the human application test begins and has prepared the written consent form.
排除标准
- •1) The subjects who have severe malignant tumors, cerebrovascular diseases (brain infarction, cerebral hemorrhage, etc.) and heart diseases (concerns, myocardial infarction, heart failure, arrhythmia requiring treatment) can participate in the human application test at the discretion of the human application tester.)
- •2) The subjects who has a vaginal and urinary tract infection as of Visit 1
- •3) The subjects with vaginal bleeding, abnormal vaginal secretion, or urinary system abnormality as of the standard of Visit1
- •4) The subjects who has been given antibiotics, antibacterial agents, steroids, and immunosuppressants within two weeks of visiting1
- •5) The subjects who has ingested health functional foods, probiotics, and lactobacillus products continuously (more than four times a week) within two weeks of visiting 1
- •6) A person who has received acupuncture treatment for women's cleanser, vaginal cleanser, sedentary treatment and vaginal health within one week of visiting 1
- •7) The subjects with unregulated hypertension (measuring standard after 10 minutes stabilization of the person subject to human application test) (above 160mmHg of blood pressure in the retractor or 100mmHg of blood pressure in the retractor).
- •8) Unregulated diabetics (if HbA1C exceeds 6.3%)
- •9) The subjects whose creatine is more than twice the normal limit of the testing agency
- •10) The subjects whose AST (GOT) or ALT (GPT) is at least three times the normal limit of the testing agency
- •11) The subjects whose TSH is less than 0.1 UU/ml or greater than 10 µU/ml
- •12) The subjects who are sensitive or allergic to the ingredients of this human-applied test food;
- •13) The subjects who is pregnant, breast-feeding, or planning to conceive within three months.
- •14) The subjects who has participated in another interventional clinical trial (including a human application test) within one month of the commencement of this human application test or who has a plan to participate in another interventional clinical trial (including a human application test) after the commencement of this human application test.
- •15) The subjects who is deemed inappropriate by the human application test testers for this human application test.
研究者
相似试验
招募中
不适用
A 8 week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of CTE on Stomach SymptomDiseases of the digestive systemKCT0005020Konkuk University Medical Center100
招募中
不适用
Clinical evaluation of extract of Ecklonia cava Kjellman on gingival healthKCT0005397Duksung Women's University50
已完成
Unknown
A 8 week, Multi-center, Randomized, Double-Blind, Placebo-Controlled Human Study for the Evaluation of the Efficacy and Safety of PMEC on Gingival healthKCT0008940MedibioLAB100
招募中
不适用
A 8 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of Magnolia extract on gingival healthKCT0006746O100
已完成
不适用
A 8 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of MAEC on gingival healthCongenital malformations, deformations and chromosomal abnormalitiesKCT0005569MedibioLAB100